Literature DB >> 10927161

Contrast-enhanced MRI of the lung.

H U Kauczor1, K F Kreitner.   

Abstract

The lung has long been neglected by MR imaging. This is due to unique intrinsic difficulties: (1) signal loss due to cardiac pulsation and respiration; (2) susceptibility artifacts caused by multiple air-tissue interfaces; (3) low proton density. There are many MR strategies to overcome these problems. They consist of breath-hold imaging, respiratory and cardiac gating procedures, use of short repetition and echo times, increase of the relaxivity of existing spins by administration of intravenous contrast agents, and enrichment of spin density by hyperpolarized noble gases or oxygen. Improvements in scanner performance and frequent use of contrast media have increased the interest in MR imaging and MR angiography of the lung. They can be used on a routine basis for the following indications: characterization of pulmonary nodules, staging of bronchogenic carcinoma, in particular assessment of chest wall invasion; evaluation of inflammatory activity in interstitial lung disease; acute pulmonary embolism, chronic thromboembolic pulmonary hypertension, vascular involvement in malignant disease; vascular abnormalities. Future perspectives include perfusion imaging using extracellular or intravascular (blood pool) contrast agents and ventilation imaging using inhalation of hyperpolarized noble gases, of paramagnetic oxygen or of aerosolized contrast agents. These techniques represent new approaches to functional lung imaging. The combination of visualization of morphology and functional assessment of ventilation and perfusion is unequalled by any other technique.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927161     DOI: 10.1016/s0720-048x(00)00199-6

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  14 in total

1.  (3)He-MRI in follow-up of lung transplant recipients.

Authors:  Klaus Kurt Gast; Julia Zaporozhan; Sebastian Ley; Alexander Biedermann; Frank Knitz; Balthasar Eberle; Joerg Schmiedeskamp; Claus-Peter Heussel; Eckhard Mayer; Wolfgang Günter Schreiber; Manfred Thelen; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2003-10-16       Impact factor: 5.315

Review 2.  Magnetic resonance imaging in lung: a review of its potential for radiotherapy.

Authors:  Shivani Kumar; Gary Liney; Robba Rai; Lois Holloway; Daniel Moses; Shalini K Vinod
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

3.  Proton MRI appearance of cystic fibrosis: comparison to CT.

Authors:  Michael Puderbach; Monika Eichinger; Julie Gahr; Sebastian Ley; Siegfried Tuengerthal; Astrid Schmähl; Christian Fink; Christian Plathow; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

Review 4.  MR imaging of the pulmonary vasculature--an update.

Authors:  Mark R Pedersen; Mark T Fisher; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

5.  Detectability of regional lung ventilation with flat-panel detector-based dynamic radiography.

Authors:  Rie Tanaka; Shigeru Sanada; Nobuo Okazaki; Takeshi Kobayashi; Masayuki Suzuki; Takeshi Matsui; Osamu Matsui
Journal:  J Digit Imaging       Date:  2008-03       Impact factor: 4.056

6.  Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging.

Authors:  Sevtap Gümüştaş; Nagihan Inan; Hasan Tahsin Sarisoy; Yonca Anik; Arzu Arslan; Ercüment Ciftçi; Gür Akansel; Ali Demirci
Journal:  Eur Radiol       Date:  2011-06-23       Impact factor: 5.315

Review 7.  Lung perfusion measured using magnetic resonance imaging: New tools for physiological insights into the pulmonary circulation.

Authors:  Susan R Hopkins; G Kim Prisk
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

8.  Quantitative pulmonary perfusion imaging at 3.0 T of 2-year-old children after congenital diaphragmatic hernia repair: initial results.

Authors:  F G Zöllner; K Zahn; T Schaible; S O Schoenberg; L R Schad; K W Neff
Journal:  Eur Radiol       Date:  2012-06-13       Impact factor: 5.315

9.  Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer.

Authors:  Julian Kirchner; Lino M Sawicki; Felix Nensa; Benedikt M Schaarschmidt; Henning Reis; Marc Ingenwerth; Simon Bogner; Clemens Aigner; Christian Buchbender; Lale Umutlu; Gerald Antoch; Ken Herrmann; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-03       Impact factor: 9.236

Review 10.  [MRT of bronchial carcinomas].

Authors:  C Fink; C Plathow; M Klopp; A Schmähl; H-U Kauczor
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.